Generated by AI
Twist Bioscience Corporation is a synthetic biology company that develops and sells DNA-based products for research and commercial applications. Twist Bioscience Corporation’s portfolio includes synthetic genes, gene fragments, oligonucleotide pools, and antibody libraries used in therapeutic discovery, diagnostics, agriculture, industrial biotechnology, and academic research. The company also supports advanced workflows such as targeted next-generation sequencing, CRISPR gene editing, mutagenesis, and DNA data storage. Its proprietary semiconductor-based DNA synthesis platform is designed to produce high-quality synthetic DNA at scale, helping customers move from design to experimentation more efficiently. Twist Bioscience Corporation serves biotechnology, pharmaceutical, industrial, and academic customers across multiple regions, making it an important supplier in the life sciences tools and synthetic biology market.
Website681 Gateway Boulevard
South San Francisco, CA, 94080
United States
The latest articles about TWST.
Summary of Nov 2's posts. Generated by AI.
Summary of Oct 28's posts. Generated by AI.
Summary of Feb 5's posts. Generated by AI.
Summary of Oct 28's posts. Generated by AI.
Investors talking about TWST also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.